Injective INJ
Innovation 55. Native on-chain orderbook L1 with MEV-resistant execution. Solid engineering, but the design follows prior orderbook-chain attempts rather than opening new ground.
What it does
Injective is a Cosmos-based Layer 1 optimized for on-chain derivatives, FX, and RWA order-book DeFi. It has a native orderbook, MEV-resistant execution, and increasingly is being used as the settlement layer for regulated wrappers of INJ-related products.
Fundamentals
- IIP-617 passed with 99.9% approval, permanently doubling INJ deflation.
- Monthly Community BuyBack is now recurring — June 2026 round deployed $315K+; participants have earned 20%+ per round.
- CFTC-approved US INJ futures live on Bitnomial (April 2026).
- Regulated Asian INJ fund M-INJ launched under Thai SEC oversight.
- ~$6.8B cumulative RWA volume; SEC transfer agent status; Pineapple Financial mortgage tokenization on Injective.
Tokenomics
- Fixed 100M supply. Effectively fully unlocked.
- Programmatic burn tied to protocol revenue.
- Deflation rate permanently doubled post IIP-617.
Catalysts (6–12mo)
- Continued regulated wrapper listings (US, Asia, potentially EU).
- RWA growth on Injective driving burn.
- Buyback compounding as protocol revenue grows.
Risks
- Cosmos ecosystem is out of favor with capital.
- Volume competition from Hyperliquid on the perp side.
- User noted "probably too well-known" — momentum-driven capital may look elsewhere.
How it compares to its peers
| L1 | Mkt cap | Revenue/yr | Growth/yr | Bull y3 rev | P/S | Fwd P/S y3 | Buyback |
|---|---|---|---|---|---|---|---|
| Sui | $3.2B | $853.4K | -41% | $327.9K | 3767.4× | 9803.5× | 0.0% |
| Aptos | $518.5M | $1.7M | -2% | $1.8M | 306.0× | 319.2× | 0.3% |
| Injective | $491.3M | $4.5M | 21% | $6.0M | 109.3× | 74.4× | 0.9% |
| Monad | $321.8M | $1.3M | 27% | $2.1M | 246.8× | 153.5× | 0.4% |
| Sei | $302.2M | $102.9K | -34% | $95.7K | 2936.4× | 6438.1× | — |
| Sonic | $101.7M | $216.3K | -36% | $94.5K | 470.3× | 1076.9× | — |
| Berachain | $55.9M | $80.6K | -36% | $230.3K | 694.2× | 1589.6× | — |
| MegaETH | $43.9M | — | -6% | — | — | — | — |
| Movement | $32.5M | $836 | -35% | $373 | 38882.2× | 87042.1× | 0.0% |
| Initia | $11.0M | — | — | — | — | — | — |
Sector median P/S is 582.3×. Injective trades at 109.3× — below the median, worth 433% if it re-rated to it. Note: this sector's peers carry very little revenue against their market caps, so the median multiple is not a meaningful valuation anchor here - the market is not pricing these on revenue. The value component is excluded from the composite score for this reason. Peer revenue growth runs at a median of -34% a year, with 7 of 9 shrinking — so this multiple sits inside a contracting sector.